Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Health Datapalooza Coincides with Release of Medicare Utilization and Payment Data
...
Register
MD Anderson Partners with Exact Sciences on Lung Cancer Tests
By Stephanie Murg, Managing Director, G2 Intelligence The University of Texas MD Anderson Cancer Center (Houston) is teaming with Exact Sciences Corp. (Madison, Wisc.) on tests that can detect lung cancer at early stages. The partnership, announced June 4, will...
Opko Acquires Bio-Reference Laboratories for $1.45 Billion
By Ron Shinkman, Editor, Laboratory Industry Report Opko Health, Inc., the Miami-based molecular lab, has come to an agreement to acquire Bio-Reference Laboratory for $1.47 billion in a stock swap deal. Opko will pay the equivalent of $52.58 per share for...
OSHA Addresses Employer Responsibility Regarding Transgender Workers
...
Register
Multidisciplinary Tumor Panels Could Ease Utility of Genomic Data
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Multidisciplinary tumor boards can improve the clinical relevance of information derived from genomic testing, according to presenters at an extended education session "Expediting the Learning...
Assistant Attorney General Says Criminal Division Fraud-Fighting Efforts Include Labs
...
Register
CCLA Loses Challenge of Pharmacogenomic LCD
...
Register
Proposed Legislation Aids Personalized Medicine Agenda
...
Register
Physicians Sentenced for Diagnostic Testing Schemes
...
Register
Fraud Case Involves Claims to Private, Not Just Federal, Payers
...
Register